Costs and Clinical Outcomes Associated with Use of Ranolazine for Treatment of Angina

Clinical Therapeutics

Volumn 34, Issue 6, 2012, Pages

  Phelps, Charles E ^a   Buysman, Erin K ^b   Gomez Rey, Gabriel ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b OPTUM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; NITRATE; RANOLAZINE;

ADULT; ANGINA PECTORIS; ARTICLE; DATA BASE; DRUG COST; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; RETROSPECTIVE STUDY; REVASCULARIZATION;

EID: 84862138606     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2012.04.025     Document Type: Article

References (21)

1. AHA heart disease and stroke statistics, update at a glance, 2010 American Heart Association (AHA), Accessed July 5, 2011. http://www.americanheart.org/downloadable/heart/1265665152970DS-3241%20HeartStrokeUpdate_2010.pdf.
2. Arnold S.V., Morrow D.A., Yang L., et al. Economic impact of angina after acute coronary syndrome: insights from the MERLIN-TIME 36 Trial. Circ Cardiovasc Qual Outcomes 2009, 2:344-353.
3. Javitz H.S., Ward M.M., Watson J.B., Jaana M. Cost of illness of chronic angina. Am J Manag Care 2004, 10(Suppl 11):S358-S369.
4. A national clinical guideline Management of stable angina, Accessed July 4, 2011. http://www.guideline.gov/content.aspx?id=10584.
5. Chaitman B.R., Skettino S.L., Parker J.O., et al. Anti-ischemic effects and long term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol 2004, 43:1375-1382.
6. Chaitman B.R., Pepine C.J., Parker J.O., et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA 2004, 29:209-316.
7. American Family Physician. Steps new drug reviews: Ranolazine (Ranexa) for chronic angina Accessed January 25, 2012. http://www.aafp.org/afp/2007/0215/p544.html.
8. Consumer Reports.org. Beta-blockers: summary of recommendations Accessed July 5, 2011. http://www.consumerreports.org/health/best-buy-drugs/beta_blockers.htm.
9. Consumer Reports.org. Calcium channel blockers: summary of recommendations Accessed July 5, 2011. http://www.consumerreports.org/health/best-buy-drugs/calcium_blockers.htm.
10. Kempf J., Buysman E., Brixner D. Resource utilization and direct costs associated with angina for patients with coronary artery disease in a US managed care setting. Am Health Drug Benefits 2011, 4:353-361.
11. Manning W.G. The logged dependent variable, heteroskedasticity, and the retransformation problem. J Health Econ 1998, 17:283-295.
12. Blough D.K., Madden C.W., Hornbrook M.C. Modeling risk using generalized linear models. J Health Econ 1999, 18:153-171.
13. Manning W.G., Mullahy J. Estimating log models: to transform or not to transform?. J Health Econ 2001, 29:461-494.
14. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
15. Quan H., Sundararajan V., Halfon P., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005, 43:1130-1139.
16. Rosengren A., Wilhelmsen L., Hagman M., et al. Natural history of myocardial infarction and angina pectoris in a general population sample of middle-aged men: a 16-year follow-up of the Primary Prevention Study, Goteborg, Sweden. J Intern Med 1998, 244:495-505.
17. Lampe F.C., Whincup P.H., Wannamethee S.G., et al. The natural history of prevalent ischemic heart disease in ion middle aged men. Eur Heart J 2000, 21:1052-1062.
18. Weintraub W.S., Spertus J.A., Kolm P., et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008, 359:677-687.
19. Gaynor M., Li J., Vogt W.B. Substitution, spending offsets, and prescription drug benefit design. Forum Health Econ Policy 2007, 10:1-31.
20. Murphy N.F., Simpson C.R., MacIntyre K., et al. Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study. Heart 2006, 92:1047-1054.
21. Hemmingway H., McCallum A., Shipley M., et al. Stable angina pectoris among women and men. JAMA 2006, 295:1404. 1411.